Page 3 - Les meilleurs doctors traitant la maladie suivante : Cancer du poumon stade 4 - TOP -81 des médecins

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Spécialiste de la virothérapie – une approche de pointe pour le traitement du cancer du poumon avec plus de 30 ans d'expérience.

• Être diplômé de l'Institut de Médecine de Riga
• Effectuer un internat en médecine interne
• Diriger le centre d'immunologie clinique de l'hôpital universitaire clinique Pauls Stradins

Le professeur Gül Alco est spécialisé en radio-oncologie pour le cancer du poumon à l'hôpital Medipol Acibadem District.

• Plus de 20 ans d'expérience en radio-oncologie
• Professeur à l'université Istanbul Medipol
• Formé à l'université d'Istanbul et à l'université Kadir Has
• A travaillé à l'hôpital Şişli Florence Nightingale

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Spécialisé en oncologie chirurgicale thoracique, y compris les chirurgies avancées du cancer du poumon au complexe hospitalier Medical Park Göztepe. Propose la thoracoscopie vidéo-assistée (VATS) pour des procédures précises et mini-invasives.

• Vaste expérience dans la chirurgie du cancer du poumon et le traitement des maladies pleurales
• Formé à l'Université Paris-Sud et à l'Hôpital Marie-Lannelongue, France
• Membre de la Société Européenne des Chirurgiens Thoraciques
• Publication de nombreux articles sur des thèmes de chirurgie thoracique

Le Dr Semenisity est spécialisé en oncologie médicale et en radiothérapie au centre médical Rambam.

• Expert en traitements avancés du cancer du poumon
• Se concentrer sur des plans de thérapie personnalisés
• Travailler avec une équipe multidisciplinaire

Le Dr Meirovitz apporte des décennies d'expertise en oncologie au centre médical Hadassah, l'un des principaux hôpitaux d'Israël.

• Diplômé de la faculté de médecine de l'université Technion en 1990
• Spécialisation dans les traitements du cancer du poumon à un stade avancé
• Pratique au Hadassah – une institution médicale de premier plan

Le professeur Tamar Jablonski-Perec dirige l'Institut d'oncologie du centre médical Hadassah, avec une formation du Sloan-Kettering Cancer Center.

• Plus de 25 ans à la tête de programmes d'oncologie
• Spécialisation dans le traitement avancé du cancer du sein et du poumon
• Membre de communautés internationales de recherche sur le cancer
• Professeur au département d'oncologie de l'Université hébraïque
• Récipiendaire de la prestigieuse bourse de l'école de médecine Hadassah

Le Dr Zalmanova est spécialisée en radiothérapie pour le cancer du poumon au centre médical Assuta.

• Radiothérapeute spécialisée dans le traitement du cancer du poumon
• Exerçant au centre médical Assuta, un établissement de premier plan en oncologie
• Établissement de plans de traitement personnalisés pour chaque patient

Spécialisé en chirurgie thoracique mini-invasive pour le cancer du poumon – le Dr Adnansayar pratique des interventions thoracoscopiques et robotisées au Liv Hospital Ulus.

• Expertise axée sur les cancers du poumon et la chirurgie de la trachée
• Compétent en transplantation pulmonaire et chirurgie des maladies pleurales
• Également expérimenté en chirurgie thoracique pédiatrique
• Diplômé de la Faculté de Médecine de l'Université d'Istanbul

Auteur de plus de 30 articles scientifiques sur le traitement des tumeurs malignes – le Dr Derin est un oncologue de premier plan à l'hôpital Liv Ulus.

• Se spécialiser dans les cancers gastro-intestinaux et pulmonaires
• Membre de l'European Society for Medical Oncology (ESMO)
• Professeur agrégé avec une vaste expérience académique
• Diplômer de la faculté de médecine de l'Université d'Istanbul

Le Dr Ece a été formée au MD Anderson Cancer Center – l'un des meilleurs hôpitaux de cancérologie au monde – avec une spécialisation dans le cancer du poumon. Elle apporte cette expertise au Liv Hospital Ulus.

• Bourse de recherche postdoctorale sur le cancer du poumon au MD Anderson
• Formée à la bronchoscopie interventionnelle à Johns Hopkins
• Membre du conseil d'administration de la Société turque du cancer du poumon
• Publication de 48 articles de recherche internationaux
• Membre (Fellow) de l'American College of Chest Physicians